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Edited by Peter BrzezinskiAbstract Mitochondrial Complex I (NADH:ubiquinone oxido-
reductase) consists of at least 46 subunits. Phosphorylation of
the 42-kDa subunit NDUFA10 was recently reported using a
novel phosphoprotein stain [Schulenberg et al. (2003) Analysis
of steady-state protein phosphorylation in mitochondria using a
novel ﬂuorescent phosphosensor dye. J. Biol. Chem. 278,
27251]. Two smaller Complex I phosphoproteins, ESSS and
MWFE, and their sites of modiﬁcation, have since been deter-
mined [Chen et al. (2004) The phosphorylation of subunits of
complex I from bovine heart mitochondria. J. Biol. Chem. 279,
26036]. Here we identify the site of phosphorylation in NDUFA10
from bovine heart mitochondria by tandem mass spectrometry. A
single phosphopeptide spanning residues 47–60 was identiﬁed and
conﬁrmed by synthesis to be (47)LITVDGNICSGKpSK(60),
establishing serine-59 as the site of phosphorylation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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NADH:ubiquininone oxidoreductase or Complex I is the
largest of the ﬁve mitochondrial electron transport chain com-
plexes with an approximate molecular weight of 980 kDa.
Complex I is a membrane bound multimeric enzyme that is
comprised of at least 46 subunits. Impairment of Complex I
activity has been described in several neurodegenerative dis-
eases, including Parkinsons disease (PD) [1,2], Alzheimers dis-
ease [3], and Huntington disease [4]. There is strong evidence
that mitochondrial Complex I inhibition can be caused in part
through accumulated damage caused by age-related oxidative
stress mediated by reactive oxygen and nitrogen species
[5–7]. For example, oxidation of cysteine residues in Complex
I [8], either through glutathionylation or S-nitrosylation
[9–11], is likely to play a role in PD. Bovine and human mito-
chondrial Complex I have been analyzed extensively and sev-
eral diﬀerent types of post-translational modiﬁcations have*Corresponding author. Fax: +1 415 209 2231.
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dative modiﬁcations [12–15]. One of the most important
post-translational modiﬁcations aﬀecting and/or regulating
enzymatic activity is protein phosphorylation. Several studies
have provided evidence of phosphorylation of subunits of
Complex I with eﬀects on electron transfer and in superoxide
production by this complex. Scacco and Papa [16–18] found
phosphorylation of subunits of Complex I with apparent
molecular weights of 6 and 18 kDa after incubation with
[32P]ATP and cAMP. These same researchers subsequently as-
signed the 18-kDa subunit as NDUFS4 (AQDQ) and demon-
strated that when cAMP levels were increased by treatment of
mouse ﬁbroblasts with cholera toxin, phosphorylation of the
18-kDa subunit increased along with Complex I activity [17].
Raha and Robinson [19] also found phosphorylation of sub-
units of Complex I with molecular weights of 18 and 6 kDa
along with a 42-kDa polypeptide when radiolabeling was car-
ried out in rat heart mitochondria in the presence of protein
kinase A. The 42-kDa protein was attributed to a contaminat-
ing protein, the E1a subunit of pyruvate dehydrogenase, and
the latter two bands to the Complex I subunits NDUFS4
(AQDQ) or NDUFB7 (B18), and NDUFA1 (MWFE), respec-
tively. Walker and colleagues [20] using Edman degradation
and mass spectrometry sequence analysis, also obtained label-
ing of two subunits of Complex I, which they identiﬁed as
ESSS (the 18-kDa protein) modiﬁed at serine-20 and MWFE
also called NDUFA1 (the 6-kDa protein) labeled at serine-
55 when bovine Complex I was incubated with radiolabeled
[32P]ATP and cAMP (and protein kinase A). Recently, a novel
phospho-speciﬁc, ﬂuorescent dye has been introduced to iden-
tify phosphoproteins. Using this method Schulenberg and col-
leagues [21,22] found staining of two subunits of Complex I
with molecular weights of 42 and 18 kDa, respectively. In these
experiments, the protein migrating at 42 kDa was assigned by
mass spectrometry as NDUFA10. Unlike the 18-kDa subunit
that required protein kinase treatment for signiﬁcant labeling
by the phospho-speciﬁc stain (Pro-Q Diamond), the 42 kDa
protein was labeled by the dye in mitochondria isolated with-
out prior kinase treatment. The above results, when considered
together, raise obvious questions. First, is the staining of
NDUFA10 really due to the presence of a covalent phosphate
or is it an artifact of the staining procedure? Also, if NDU-
FA10 is a phosphoprotein what residues are involved? In an
attempt to resolve these questions we have used on-lineblished by Elsevier B.V. All rights reserved.
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by sucrose gradient fractionation or immunoprecipitation of
untreated bovine heart mitochondria.2. Materials and methods
2.1. Materials
NuPAGE 12.5% Bis–Tris gels, MES running buﬀer, SYPRO Ruby
and Pro-Q Diamond ﬂuorescent protein gel stains were obtained from
Molecular Probes/Invitrogen. For proteolysis, sequencing grade, mod-
iﬁed trypsin (porcine) was purchased from Promega. N-dodecyl-b-D-
maltoside was purchased from Calbiochem. Additional reagents for
protein chemistry were obtained from Sigma. HPLC solvents were
obtained from Burdick & Jackson. For MALDI-MS experiments, a
matrix solution of a-cyano-4-hydroxycinnamic acid in acetonitrile/
methanol was purchased from Agilent Technologies. The two synthetic
phosphopeptides, LITVDGNICpSGKSK and LITVDGNICSGKpSK
(pS is phosphoserine), were custom synthesized and purchased from
Princeton Biomolecules Corporation.
2.2. Isolation of bovine heart Complex I
Mitochondria were prepared from bovine heart by homogenizing,
ﬁltration, and diﬀerential centrifugation as described previously [23].
Complex I was then isolated and puriﬁed from bovine heart mitochon-
dria by either a sucrose gradient centrifugation protocol [24,25] or an
immunoisolation protocol where Complex I was immunocapturing in-
tact as reported by Murray et al. [13].
2.3. Dephosphorylation of Complex I
Complex I obtained from the sucrose gradient was treated with bo-
vine alkaline phosphatase (AP) after adjusting pH to 8.8 and supple-
menting the buﬀer with 2 mM MgCl2 and 1% SDS. The
dephosphorylation of 50 lg Complex I was carried out in 100 ll at
35 C for 2 h using 5 U of bovine AP. After neutralizing the pH with
3 ll 10% TFA samples were pelleted with chloroform/methanol. Pellets
were redissolved in 50 ll dissociation buﬀer containing 50 mM DTT.
Samples were then heated to 95 C for 5 min, spun down and 15 lg
were applied on a 12.5% minigel, which was stained with Pro-Q Dia-
mond (D) phosphoprotein stain followed by SYPRO Ruby (S) protein
gel stain according to the manufacturers instructions (Invitrogen). Ra-
tios of the staining intensities D/S were determined with ImageGauge
(FUJI Film, Tokyo, Japan) using a 473 nm excitation for the SYPRO
Ruby dye and a 532 nm excitation for Pro-Q Diamond dye (580 nm
emission ﬁlter).
2.4. In-gel tryptic digestion of proteins
Protein bands of interest were manually excised out of the gel and
processed with an automatic in-gel digester robot (ProGest, Genomic
Solutions). The gel bands were destained and dehydrated with acetoni-
trile, the proteins were reduced with 10 mM DTT (60 C, 30 min), and
the reduced cysteine residues were then alkylated with 100 mM iodoa-
cetamide (37 C, 45 min). Prior to enzymatic digestion excess reagents
were removed and the gel pieces were washed twice with 25 mM
ammonium bicarbonate, dehydrated, and incubated with 250 ng
sequencing grade trypsin (37 C for 4 h). The resulting tryptic peptides
were extracted from the gel with 10% formic acid as previously
described [26].
2.5. Mass spectrometry and database searches
Digested protein gel bands and synthetic peptide samples were ini-
tially analyzed by matrix-assisted laser desorption ionization time-
of-ﬂight (MALDI-TOF) mass spectrometry on a Voyager DE STR
plus instrument (Applied Biosystems). Mass spectra were acquired in
positive-ionization mode with reﬂectron optics as described previously
[27]. All samples were then analyzed by reverse-phase nano-HPLC-
MS/MS. Brieﬂy, peptides were separated on an Ultimate nanocapillary
HPLC system equipped with a PepMape C18 nano-column (75 lm
I.D. · 15 cm) (Dionex) and CapTrap Micro guard column (0.5 ll
bed volume, Michrom) as recently reported [27]. The nano-HPLC col-
umn eluant was directly coupled to a ‘‘QSTAR Pulsar i’’ quadrupole
orthogonal TOF mass spectrometer (MDS Sciex) equipped with aProXeon nanospray ion source (ProXeon Biosystems). ESI-MS/MS
mass spectra were acquired as previously described [27]. Mass spectro-
metric data were analyzed using the search engine Mascot (Matrix Sci-
ence) [28]. A custom-designed ‘‘bovine Complex I’’ protein database
was incorporated into our in-house licensed Mascot server as previ-
ously described [26].
2.6. Synthetic phosphopeptides
The two custom synthesized phosphopeptide isomers, LITVDG-
NICpSGKSK, and LITVDGNICSGKpSK were diluted with 50 mM
ammonium bicarbonate to a concentration of 400 lM. The peptides
were reduced with a 500-fold molar excess of DTT (60 C, 60 min),
and then alkylated with a 1100-fold molar excess of iodoacetamide
(37 C, 45 min).3. Results
In this current study, we ﬁrst investigated the phosphoryla-
tion status of bovine Complex I under steady-state conditions
isolated from heart tissue by either sucrose gradient fraction-
ation [24,25] or immunoprecipitation [13]. This material was
separated by 1D SDS–PAGE and stained ﬁrst with a phos-
pho-speciﬁc ﬂuorescent dye (Pro-Q Diamond) and then with
a total-protein stain (SYPRO Ruby) so that all subunits could
be visualized. The methods used for Complex I puriﬁcation
and subunit separation and visualization had been previously
described in several recent reports, including a one-step puriﬁ-
cation method for human Complex I from mitochondria [13]
and detailed mass spectrometry analysis of both bovine and
mouse Complex I subunits [26].
The subunit proﬁle of the bovine Complex I proteins puri-
ﬁed by sucrose gradient fractionation and then separated by
1D SDS–PAGE is shown in Fig. 1. The major band showing
signiﬁcant phospho-speciﬁc staining (Fig. 1A) migrated at
42-kDa and corresponds to the NDUFA10 subunit. This
observation is consistent with previous data by Schulenberg
et al. [21,22] where a similar high staining band was identiﬁed
as this subunit. In addition, Fig. 1A and B lanes 2–4 show
incubation experiments of mitochondria with AP under dif-
ferent conditions of incubation (see Fig. 1, legend). The ﬂuo-
rescence signal obtained after Pro-Q Diamond (Fig. 1A) and
SYPRO Ruby (Fig. 1B) staining was quantiﬁed both before
and after AP treatment using Image Gauge (FUJI Film, To-
kyo) to determine the phosphorylation level for the NDU-
FA10 gel band. The phospho-speciﬁc ﬂuorescent signal was
compared as a ratio with the same sample stained with SY-
PRO Ruby (Pro-Q Diamond/SYPRO Ruby, D/S) and was
expressed in percent of the control lane 1 where no AP was
added which was deﬁned as 100% (lane 1, D/S: 0.47). AP
treatment was then carried out with and without the addition
of detergent, the latter of which led to a slight decrease in
ﬂuorescent signal to 97% of control (lane 2, D/S: 0.46). When
treatment with AP was carried out in the presence of 1% lau-
rylmaltoside (lane 3) a further but incremental decrease was
observed to 93% of control (D/S: 0.44). In the presence of
1% SDS (lane 4), however, a signiﬁcant decrease to 47% of
the control was observed (D/S: 0.22), suggesting the presence
of a phosphoprotein. The small decrease in signal after AP
treatment without detergent or with 1% laurylmaltoside is
presumably due to low accessibility of this phosphorylation
site under the conditions used in the isolation of Complex
I, conditions that would keep Complex I largely intact and
NDUFA10 subunit in its native conﬁguration, although not
Fig. 1. Alkaline phosphatase (AP) treatment of Complex I from sucrose gradient. A 1D SDS–PAGE gel was stained for phosphoprotein using Pro-Q
Diamond phosphoprotein gel stain (A) before post-staining with SYPRO Ruby protein gel stain (B) for a total protein proﬁle. Lane 1 (both panels)
shows a control sample of 15 lg Complex I without addition of detergent or AP. Alkaline phosphatase treatment was carried out without addition of
detergent (lane 2), and in the presence of 1% laurylmaltoside (lane 3) or 1% SDS (lane 4). Lane 5 (named Std) shows a broad range molecular weight
marker containing ovalbumin as a positive control (Bio-Rad Laboratories). NDUFA10 is indicated (as ‘‘A10’’) in both panels at a molecular weight
of around 42 kDa.
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within the mitochondria.
To determine the site-speciﬁc features of Complex I phos-
phorylation, we analyzed the NDUFA10 band by mass spec-
trometry. Previously, we performed a thorough mass
spectrometric analysis of immunocaptured bovine Complex I
that was separated by 1D SDS–PAGE as shown in Fig. 1A
and B, identifying 43 out of 46 bovine Complex I protein sub-
units [26]. In this current work, we focused our attention to-
wards an in depth analysis and sequence assignment of the
‘‘phosphorylated’’ NDUFA10 subunit. After excision of the
protein from the gel and digestion with trypsin, the sample
was subjected to initial MALDI MS analysis. In this experi-
ment, 10 peptide masses (or ﬁngerprints) were detected by
MALDI MS for subunit NDUFA10, yielding a sequence cov-
erage of 35% (data not shown).
Toobtainmore sequence coverage and to identify the site(s) of
phosphorylation, the tryptic digestion mixture of the NDU-
FA10 gel band was then investigated by nano-HPLC-ESI-MS/
MS. The resulting tandem mass spectra were analyzed using a
Mascot database search that allowed for post-translational
modiﬁcations, including phosphorylation. From this data set,
a precursor ion selected for MS/MS, [M + 2H]2+ at m/z
786.32+ (M = 1570.62), wasmatched to amono-phosphorylated
peptide with the sequence corresponding to an expected tryptic
peptide spanning Leu-47 to Lys-60 of the NDUFA10 subunit,
i.e., L47ITVDGNICSGKSK60 (NDUFA10 sequence number-
ing is based on the protein precursor and not the mature protein
which contains a N-terminal 23 amino acid import sequence
which is removed post-translationally). Fragmentation analysis
clearly showed the presence of one phosphate group on either
serine residue Ser-56 or Ser-59 (shown in bold type above). Spe-
ciﬁcally, a series of y-type fragment ions and several b-type frag-
ment ions were observed. For example, the b3 and b3-H2O ion
pair at m/z 328.2 and 310.2, clearly indicate a non-phosphory-
lated threonine at position 49. Several y-type ions were also
observed along with their yn-98 ion counterparts, the latter of
which results from neutral loss of phosphoric acid (–H3PO4)
[29]. These fragment ion pairs were observed at m/z 746.4/648.3 (y6/y6-98), 1030.6/932.5 (y9/y9-98), 1145.5/1047.5 (y10/
y10-98), and 1345.7/1247.7 (y12/y12-98), indicating the presence
of a phosphate in the C-terminal part of this peptide at either
Ser-56 or Ser-59. The presence of a few smaller fragment ions
at m/z 488.3, 401.3, 344.2, and 216.1, were tentatively assigned
as yn-P ions (n = 2–5), suggesting Ser-59 as the site of phosphor-
ylationandnotSer-56, i.e.,LITVDGNICSGKpS59K.Toeliminate
the possible phosphorylation of serine-56, the two mono-
phosphorylated peptide isomers LITVDGNICSGKpS59K and
LITVDGNICpS56GKSK were synthesized de novo, alkylated,
and analyzed by nano-HPLC-ESI-MS/MS mass spectrometry
for comparison.
Fig. 3 shows the ESI-MS/MS spectra of carbamidomethy-
lated synthetic peptides LITVDGNICSGKpS59K (Fig. 3A)
and LITVDGNICpS56GKSK (Fig. 3B). Fragmentation pat-
tern of the two mono-phosphorylated peptide isomers appear
very similar and correspond well to the overall fragmentation
of the native phosphopeptide isolated from bovine Complex I
(compare Fig. 2). Upon detailed inspection of the tandem mass
spectra for the synthetic peptides, subtle but signiﬁcant diﬀer-
ences were delineated that allowed for the determination of the
speciﬁc phosphorylation site as Ser-59 (see Fig. 4). In these
spectra, the mass ranges from m/z 140–500 are displayed for
the native phosphopeptide isolated from bovine bovine NDU-
FA10 (Fig. 4A), and the two synthetic peptides, LIT-
VDGNICSGKpS59K (Fig. 4B) and LITVDGNICpS56GKSK
(Fig. 4C); these peptides are further referred to as native pep-
tide LITV-A10 and synthetic peptides LITV-pS-59 and LITV-
pS-56, respectively. Signiﬁcant diﬀerences in fragmentation
can be seen among these peptides in the low mass region for
the relevant y-ions. In particular, peptide LITV-pS-56 shows
an abundant y2-ion at m/z 234.1 that indicates an unmodifed
Ser-59 (Fig. 4C), whereas peptide LITV-pS-59 (Fig. 4B) and
native peptide LITV-A10 (Fig. 4A) do not show a peak at this
m/z value (m/z 234). Instead LITV-pS-59 and LITV-A10 show
a relatively weak y2-ion at m/z 314.1 and a much stronger char-
acteristic y2-98 (y2-P) ion at m/z 216.1 corresponding to a phos-
phate group on Ser-59 (the abundant m/z 216.1 ion is not
present inLITV-pS-56 as expected). Several other distinguishing
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Fig. 3. ESI-MS/MS spectrum of mono-phosphorylated, custom syn-
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VDGNIC\pS56GKSK (B). In each case, the molecular ion, [M + 2H]2+
at m/z 786.32+ (M = 1570.62), was selected for collision induced
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4C) shows an abundant ion at m/z 419.3 (y4), with a less abun-
dant ion at m/z 362.2 (y3) which are both absent in the spectraof LITV-pS-59 and LITV-A10 (Fig. 4B and A). Peptides
LITV-pS-59 and LITV-A10, both show ions at m/z 401.1
(y4-98), 344.2 (y3-98), and 433.2 (CS
56GK, internal ion,
unmodiﬁed Ser-56), that on the other hand were not observed
in LITV-pS-56. Thus, we can conclude that the phosphate
group of the native peptide LITV-A10 isolated from bovine
Complex I (NDUFA10) is located on serine-59 alone.
Phosphorylation of Ser-59 is also consistent with the ob-
served proteolytic properties of bovine protein NDUFA10.
While the phosphorylated peptide was observed as LIT-
VDGNICSGKpS59K, the same non-phoshorylated version of
this peptide was not observed. Rather, a shorter peptide LIT-
VDGNICSGK was observed, suggesting that the phosphory-
lation of Ser-59 blocks the proteolytic cleavage at Lys-58; in
the absence of the Ser-59 phosphate group tryptic cleavage
immediately occurs again at Lys-58 and thus the longer
non-phosphorylated peptide LITVDGNICSGKS59K is not
observed.4. Discussion
In bovine NDUFA10, a single amino acid, serine-59, was
identiﬁed by tandem mass spectrometry to be phosphorylated.
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NDUFA10 still to be identiﬁed, careful analysis of all MS
and MS/MS data revealed no evidence for additional sites.
This observation represents the ﬁrst time that an endogenous
phosphorylation site has been identiﬁed unequivocally at the
amino acid level in mammalian Complex I that was not in-
duced by prior kinase treatment. In a recent report by Walker
and colleagues [20], for example, neither of the two subunits
that were found to be phosphorylated after kinase treatment,
ESSS and MWFE, appear to be phosphorylated when isolated
directly from mitochondria.
NDUFA10 is located in the hydrophobic membrane arm
(subcomplex Ic) that is embedded in the mitochondrial inner
membrane [30]. However, unlike other protein components
of the membrane arm, the NDUFA10 subunit is a relatively
hydrophilic protein and is thought to be only loosely associ-
ated with the Ic subcomplex [30]. Presumably, this would make
the NDUA10 subunit more accessible to external interactions
with other non-Complex I proteins, such as kinases and phos-
phatases, although details of the structure of NDUA10 that
might support such interactions are currently unavailable. Re-
cently, published data from 2D gel separations of bovine Com-
plex I showed multiple spots for the NDUFA10 subunit
reﬂecting a shift in its pI values [21,31]. These multiply resolved
‘‘trains’’ of spots seen on a 2D SDS–PAGE gel may indicate
diﬀerential phosphorylation, although other possible explana-
tions, such as deamidation [32], acetylation or methylation,
could also produce such a pattern. However, the only other
modiﬁcation that we found for bovine protein subunit NDU-
FA10 besides phosphorylation was a tryptophan oxidation to
formylkynurenin, which would not cause a change in pI val-
ues. Several post-translational and non-enzymatic modiﬁca-
tions have been reported for protein subunits of bovine and
mouse Complex I [26,31], although no phosphorylation sites
have been identiﬁed without prior kinase treatment
[16,17,19,20]. In NDUFA10 isolated from bovine Complex I,
however, Schulenberg et al. [21] observed several NDUFA10
isoforms after 2D gel separation, some of which stained pref-
erentially with the phospho-speciﬁc stain Pro-Q Diamond.
This latter observation indicated that protein phosphorylation
was the basis for this heterogeneity, and this has now been con-
ﬁrmed in this current mass spectrometric study. Similarly, we
have also observed a multiple spot pattern in the 2D gel anal-
ysis of mouse NDUFA10 (unpublished data, Gibson and
Andersen) suggesting that there is likely other site(s) of phos-
phorylation in this subunit distinct from the site identiﬁed in
this study, as there is no corresponding hydroxyl-containing
amino acid at position Ser-59 in the mouse sequence (see
Fig. 5). Indeed, if one considers other animal models com-
monly used in aging and neurodegenerative disease research,
only Caenorhabditis elegans and Drosophila (Fig. 5) have a ser-Fig. 5. Sequence homology of bovine a10 subunits among other
species surrounding phosphorylation site serine-59 (boxed), other
potential sites are shown in bold.ine (or threonine) at this position. However, examination of
the immediate ﬂanking regions of serine-59 among bovine, hu-
man, rodent, C. elegans and Drosophila, showed that there are
several other sites that are conserved in two or more of the spe-
cies that have consensus motifs for S/T kinases. Experiments
are now underway to investigate these potential phosphoryla-
tion sites in more detail.
The mitochondrial kinase that is responsible for the phos-
phorylation of NDUFA10 has not yet been determined. How-
ever, the consensus motif surrounding Ser-59 suggests a casein
kinase I-like activity. Recently, a mutation in the gene encod-
ing a novel mitochondrial kinase, PTEN-induced kinase 1 (or
PINK1), was shown to result in an hereditary form of early on-
set PD [33]. While it is too early to speculate whether a corre-
lation exists between PINK1 kinase and Complex I
phosphorylation, including the novel phosphorylation site
identiﬁed here, it is worth noting that Complex I dysfunction
is one of the earliest detectable biochemical features of PD.
It is also worth noting that NDUA10 has been referred to as
‘‘mammalian-speciﬁc’’ subunit of Complex I [34], even though
it is present in some higher non-mammalian eukaryotes. None-
theless, its apparent absence in lower eukaryotes such as N.
crassa (fungus), Arabidopsis thaliana and Chlamydomonas rein-
hardtii (plant/green algae) [34], suggests that NDUA10 has ap-
peared late in mitochondrial evolution, consistent with a more
regulatory role for this phosphoprotein. Indeed, future studies
are planned to examine the consequence of NDUFA10 phos-
phorylation and identify the kinase involved, information that
will hopefully provide some insight on its function in Complex
I function or assembly.
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